MRNX
Defiance Daily Target 2X Long MRNA ETF
MRNX
Closed
$24.27
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
MRNX was created on 2026-02-03 by Defiance. The fund's investment portfolio concentrates primarily on health care equity. MRNX seeks to deliver 2x leveraged exposure to the daily share price movement of Moderna, Inc. (NASDAQ: MRNA), net fees and expenses, through derivatives like swap agreements. MRNA develops mRNA-based vaccines and therapies, best known for its COVID-19 vaccine.
Company
Defiance
Asset class
Equity
Inception date
2026
Investment segment
Health Care
ISIN
US88636X8157
Website
Key stats
Open
$27.69
Volume
16.74K
AUM
$2.18M
Prev. close
$24.27
Expense ratio
1.31%
P/E
0.00
$22.18
Day’s Range
$28.19
$14.95
52W Range
$62.80
What’s in the fund
11
Total holdings
US DOLLARS
77.17%
MODERNA INC.-SWAP-JNST-L
41.32%
MODERNA INC.-SWAP-NBCB-L
41.32%
MODERNA INC SWAP CS-L
41.16%
MODERNA INC SWAP NOMURA-L
37.56%
MODERNA INC SWAP MAREX-L
27.54%
United States Treasury Bills 0%
17.41%
MODERNA INC SWAP CF-L
16.15%
First American Government Obligs X
8.06%
Others
-207.69%
Returns
Performance
_
Difference
_
Defiance Daily Target 2X Long MRNA ETF
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply